Champions Oncology (CSBR) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Champions Oncology (CSBR) over the last 14 years, with Q4 2025 value amounting to $357000.0.
- Champions Oncology's Accumulated Depreciation & Amortization fell 1052.63% to $357000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $357000.0, marking a year-over-year decrease of 1052.63%. This contributed to the annual value of $1.6 million for FY2025, which is 1368.42% down from last year.
- Per Champions Oncology's latest filing, its Accumulated Depreciation & Amortization stood at $357000.0 for Q4 2025, which was down 1052.63% from $358000.0 recorded in Q3 2025.
- Champions Oncology's 5-year Accumulated Depreciation & Amortization high stood at $2.2 million for Q2 2023, and its period low was $279000.0 during Q1 2021.
- In the last 5 years, Champions Oncology's Accumulated Depreciation & Amortization had a median value of $465000.0 in 2024 and averaged $748450.0.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 6656.15% in 2022, then plummeted by 2026.73% in 2025.
- Quarter analysis of 5 years shows Champions Oncology's Accumulated Depreciation & Amortization stood at $346000.0 in 2021, then soared by 61.85% to $560000.0 in 2022, then dropped by 13.57% to $484000.0 in 2023, then dropped by 17.56% to $399000.0 in 2024, then dropped by 10.53% to $357000.0 in 2025.
- Its Accumulated Depreciation & Amortization was $357000.0 in Q4 2025, compared to $358000.0 in Q3 2025 and $1.6 million in Q2 2025.